(Q24653006)

Ola Landgren

0 references

S. Vincent Rajkumar

S Vincent Rajkumar

0 references

Ruth Pfeiffer

Ruth M Pfeiffer

0 references

Shaji K Kumar

Shaji Kumar

0 references

Neil Caporaso

Neil E Caporaso

0 references

Jerry A Katzmann

Jerry A Katzmann

0 references

Raynell J Clark

Raynell J Clark

0 references

Robert N. Hoover

Robert Hoover

0 references

author name string

Dalsu Baris

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

0 references

language of work or name

English

0 references

publication date

28 May 2009

0 references

published in

Blood

0 references

volume

113

0 references

issue

0 references

page(s)

5412-7

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Longitudinal data analysis for discrete and continuous outcomes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Pathogenesis and progression of monoclonal gammopathy of undetermined significance

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Prevalence of monoclonal gammopathy of undetermined significance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Advances in biology of multiple myeloma: clinical applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Multiple myeloma: evolving genetic events and host interactions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Methods for etiologic and early marker investigations in the PLCO trial.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689042

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19179464

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Monoclonal gammopathy of undetermined significance. Natural history in 241 cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19179464

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2008-12-194241

1 reference

1 reference

1 reference

PubMed publication ID

19179464

1 reference